Device | Reference | Patients n/Diagnosis | IL-6 Method/Effect | IL-8 Method/Effect | IL-10 Method/Effect | TNF Method/Effect | sTNF-αR1+2 Method/Effect |
---|---|---|---|---|---|---|---|
MARS | Guo et al. [22] | 11/ALF 13/ACLF | FACS/Decrease | ELISA/Decrease | FACS/No change | FACS/Decrease | Not available |
MARS | Ambrosino et al. [20] | 17/ACLF | Not provided/Increase | Not available | Not available | Not provided/Decrease | Not available |
MARS | Sen et al. [19] | 18/ACLF | ELISA/No change | ELISA/No change | ELISA/No change | ELISA/No change | ELISA/No change |
MARS | Auth et al. [21] | 2/ALF | ELISA/Decrease in albumin circuit | Not available | Not available | ELISA/Decrease in albumin circuit | Not available |
MARS | Isoniemi et al. [33] | 49/ALF | ELISA/No change | ELISA/No change | ELISA/Decrease | ELISA/No change | Not available |
MARS | Di Campli et al. [23] | 10/ALF | ELISA/Decrease | Not available | Not available | ELISA/Decrease | Not available |
Prometheus | Rifai et al. [9] | 7/ACLF 2/Graft dysfunction | ELISA/No change | Not available | Not available | ELISA/No change | Not available |